- Treatment of Attention-Deficit Hyperactivity Disorder
-
Kim YK, Song DH
- KMID: 2188014
- J Korean Med Assoc.
- 2009 May;52(5):489-499.
- doi: 10.5124/jkma.2009.52.5.489
This article presents the knowledges regarding the evaluation and the management of attention-deficit/hyperactivity disorder (ADHD). Probably the most important components to a comprehensive evaluation of patients with ADHD, are the... -
- CITED
-
- Close
- SHARE
-
- Close
- Use of Atypical Antipsychotics in Attention-Deficit Hyperactivity Disorder
-
Song MA, Hong HJ
- KMID: 2287458
- Korean J Psychopharmacol.
- 2013 Jan;24(1):11-17.
Psychopharmacotherapy is one of the effective treatments for the children and adolescents with attention-deficit hyperactivity disorder (ADHD). If there were a marginal improvement or significant adverse effects after having the... -
- CITED
-
- Close
- SHARE
-
- Close
- Non-Stimulant Medications in the Treatment of Attention-Deficit Hyperactivity Disorder
-
Hwang JW
- KMID: 2291724
- J Korean Acad Child Adolesc Psychiatry.
- 2008 Jun;19(2):72-82.
The aim of this paper is to evaluate the use of non-stimulants, including atomoxetine, bupropion and modafinil, as alternative approaches to the treatment of children with attention-deficit hyperactivity disorder. A... -
- CITED
-
- Close
- SHARE
-
- Close
- Treatment for Attention-Deficit/Hyperactivity Disorder in Adults
-
Yang J, Kim JH, Kim JW, Choi J, Hong HJ, Joung YS
- KMID: 2172669
- J Korean Acad Child Adolesc Psychiatry.
- 2012 Oct;23(Suppl):S72-S89.
This review examined the treatment of attention-deficit/hyperactivity disorder (ADHD) in adults. It briefly addresses the issues about the cause of hospital visit, diagnosis, and impact of disease, specific to adults.... -
- CITED
-
- Close
- SHARE
-
- Close
- Iptakalim Preferentially Decreases Nicotine-induced Hyperlocomotion in Phencyclidine-sensitized Rats: A Potential Dual Action against Nicotine Addiction and Psychosis
-
Volf N, Hu G, Li M
- KMID: 1432539
- Clin Psychopharmacol Neurosci.
- 2012 Dec;10(3):168-179.
- doi: 10.9758/cpn.2012.10.3.168
OBJECTIVE: Iptakalim is a putative ATP-sensitive potassium (KATP) channel opener. It is also a novel nicotinic acetylcholine receptor (nAChR) blocker and can antagonize nicotine-induced increase in dopamine release in the... -
- CITED
-
- Close
- SHARE
-
- Close
- Screening of functional components derived from fresh water laver, Prasiola japonica, and its pharmacological properties
-
Seo DW, Kim HJ, Jang SK, Jun M, Joo SS
- KMID: 1498926
- J Biomed Res.
- 2013 Jun;14(2):83-90.
The aim of the current study was to analyze the active ingredients and to screen the pharmacological properties of freshwater laver, Prasiola japonica, the only species grown in Korea. According... -
- CITED
-
- Close
- SHARE
-
- Close
- A Randomized, Open-Label Assessment of Response to Various Doses of Atomoxetine in Korean Pediatric Outpatients with Attention-Deficit/Hyperactivity Disorder
-
Cho S, Lee SI, Yoo H, Song DH, Ahn DH, Shin DW, Yum SY, Walton R, Mendez L
- KMID: 2316041
- Psychiatry Investig.
- 2011 Jun;8(2):141-148.
OBJECTIVE: This multicenter, randomized, open-label, parallel trial aimed to provide a detailed dose-response profile for atomoxetine in Korean pediatric outpatients with attention-deficit/hyperactivity disorder (ADHD). METHODS: Male and female outpatients aged 6-18... -
- CITED
-
- Close
- SHARE
-
- Close
- A case report of alverine-citrate-induced acute hepatitis
-
Han JY, Lee JW, Kim JM, Joo K, Chon U, Lee JI, Jeong S, Lee DH, Kim YS, Min KS
- KMID: 1782223
- Korean J Hepatol.
- 2010 Mar;16(1):75-78.
- doi: 10.3350/kjhep.2010.16.1.75
Alverine citrate is one of the most commonly used antispasmodic drugs for patients with irritable bowel syndrome. Alverine-citrate-induced hepatotoxicity is extremely rare, with only a few cases having been reported... -
- CITED
-
- Close
- SHARE
-
- Close
- Multi Target Neuroprotective and Neurorestorative Anti-Parkinson and Anti-Alzheimer Drugs Ladostigil and M30 Derived from Rasagiline
-
Youdim MB
- KMID: 2165435
- Exp Neurobiol.
- 2013 Mar;22(1):1-10.
- doi: 10.5607/en.2013.22.1.1
Present anti-PD and -AD drugs have limited symptomatic activity and devoid of neuroprotective and neurorestorative property that is needed for disease modifying action. The complex pathology of PD and AD... -
- CITED
-
- Close
- SHARE
-
- Close
